• Blog
  • Transplant Diagnostics Market Analysis | 2023-2028

    Transplant Diagnostics Market Analysis | 2023-2028

    Transplant Diagnostics Market Analysis | 2023-2028
    Report code - SRHL309 Delivery - 2 Weeks
    Transplant Diagnostics Market Size, Share, Trend, Forecast & Industry Analysis: 2 See more...

    Market Insights

    “The Transplant Diagnostics Market was estimated at US$ 4.2 billion in 2022 and is expected to grow at a CAGR of 7.6% during 2023-2028 to reach US$ 6.54 billion by 2028.”

    Wish to get a free sample? Register Here

    What is the Transplant Diagnostics?

    Transplant diagnostics refers to the specialized field of medical diagnostics focused on assessing the compatibility between organ or tissue donors and recipients in transplantation procedures. It involves a range of tests and techniques aimed at determining the suitability of a donor organ or tissue, identifying potential risks of rejection, and monitoring the transplant's progress post-procedure. These diagnostics include human leukocyte antigen (HLA) typing, cross-matching, serological testing, and molecular diagnostics. Transplant diagnostics play a crucial role in ensuring successful transplantation outcomes by facilitating precise matching and minimizing the risk of graft rejection, thereby enhancing patient safety and improving long-term graft survival.

    Transplant Diagnostics Market Report Overview

    Market Size in 2028

    USD 6.54 Billion

    Market Size in 2022

    USD 4.2 Billion

    Market Growth (2023-2028)

    7.6%

    Base Year of Study

    2022

    Trend Period

    2017-2021

    Forecast Period

    2023-2028

    Segments Covered

    By Technology Type (Molecular Assay Technologies & Non-Molecular Assay Technologies)

    By Product & Service Type (Instrument, Reagent & Consumables, and Software)

    By Application Type (Diagnostic Applications & Research Applications)

    By Transplant Type (Solid Organ Transplantation, Stem Cell Transplantation, Soft Tissue Transplantation, and Bone Marrow Transplantation)

    By End-User Type (Independent Reference Laboratories, Hospitals & Transplant Centers, and Research Laboratories & Academic Institutes)

    By Region (North America, Europe, Asia-Pacific, & the Rest of the World)

    Dominant Region

    North America is expected to be dominant throughout the forecast period.

    Market Dynamics

    The transplant diagnostics market is experiencing significant growth due to various factors. One of the primary drivers is the increasing demand for organ and tissue transplantation procedures. This demand is fueled by advancements in transplant technologies, such as precision medicine and personalized transplantation strategies. These innovations have a positive impact on the market by improving outcomes and enhancing compatibility assessment.

    Stringent regulatory guidelines also play a crucial role in driving the adoption of transplant diagnostic tests. The need for accurate compatibility assessment, as mandated by these guidelines, is leading to increased market demand. Moreover, the market is expanding due to the growing emphasis on reducing transplant rejection rates and improving patient outcomes. These factors highlight the importance of transplant diagnostic tests in ensuring successful transplantation.

    Collaborations and partnerships between diagnostic companies and transplant centers are other key factors contributing to market development. By combining their expertise and resources, these collaborations aim to advance transplant diagnostics and meet the evolving needs of the market.

    Overall, the transplant diagnostics market is expected to maintain steady growth as a result of these dynamic factors.

    Segments Analysis

    Transplant-Diagnostics-Market-Dominant-Segments

    Want to get more details about the segmentations? Register Here

    Technology Insights

    "The molecular assay technology segment accounted for the largest market share."

    The market is segmented into molecular assay technologies and non-molecular assay technologies. The molecular assay technology segment held the larger share of the market and is expected to remain dominant during the forecast period. The higher share is attributed to properties of molecular assay technologies such as higher procedural efficacy and real-time sample analysis.

    Product & Service Insights

    "The reagent & consumable segment accounted for the largest market share."

    The market is segmented into instruments, reagents & consumables, and software. The reagent & consumable segment accounted for the largest share, owing to the frequency of usage and technological advancement in transplantation procedures. It is likely to dominate the market during the forecast period as well.

    Application Insights

    "The diagnostic applications segment accounted for the largest market share."

    The market is segmented into diagnostic applications and research applications. The diagnostic applications segment accounted for the larger share of the market, owing to the huge adoption of advanced molecular techniques for pathogen detection. The segment is expected to maintain its dominance during the forecast period as well.

    Transplant Insights

    "The solid organ transplantation segment accounted for the largest market share."

    The market is segmented as solid organ transplantation, stem cell transplantation, soft tissue transplantation, and bone marrow transplantation. The solid organ transplantation segment accounted for the largest share, on account of the rising incidences of cardiovascular, renal, lung, and liver disease across the globe.

    End-User Insights

    "The hospital & transplant centers segment accounted for the largest market share."

    Based on the end-user type, the market is segmented as independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. The hospital & transplant centers segment captured the largest share of the market and is likely to lead the market during the forecast period, owing to high patient footfall coupled with the high budget of such healthcare facilities across the globe.

    Regional Trends

    "North America accounted for the largest market share."

    North America is projected to be the largest market for transplant diagnostics during the forecast period. The North American market is expected to expand with a lucrative CAGR due to the well-established medical device market, high healthcare expenditure, and huge demand majorly from the US.

    Want to know which region offers the best growth opportunities? Register Here

    Key Players

    The market is highly populated with the presence of several local, regional, and global players. Most of the major players compete in some of the governing factors including price, product offerings, regional presence, etc. 

    The following are the key players in the transplant diagnostic market (arranged alphabetically).

    • Becton
    • Biofortuna
    • Biomérieux SA
    • Bio-Rad Laboratories
    • Caredx
    • Dickinson and Company
    • F. Hoffman-La Roche Limited
    • Gendx
    • Hologic, Inc.
    • Illumina, Inc.
    • Immucor, Inc.
    • Luminex Corporation
    • Merck KGaA
    • Omixon
    • Qiagen Nv
    • Thermo Fisher Scientific.

    Note: The above list does not necessarily include all the top players in the market.

    Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

    Report Features

    This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Transplant Diagnostics Market

    How lucrative is the future?

    The market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    What are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Customization Option

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players).
    • SWOT analysis of key players (up to 3 players). 

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Technology portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Transplant diagnostics refers to the specialized field of medical diagnostics focused on assessing the compatibility between organ or tissue donors and recipients in transplantation procedures. It involves a range of tests and techniques aimed at determining the suitability of a donor organ or tissue, identifying potential risks of rejection, and monitoring the transplant's progress post-procedure. These diagnostics include human leukocyte antigen (HLA) typing, cross-matching, serological testing, and molecular diagnostics.

    The Transplant Diagnostics Market is expected to grow at a CAGR of 7.6% during 2023-2028.

    Becton, Dickinson and Company, Biofortuna, Biomérieux SA, Bio-Rad Laboratories, Caredx, F. Hoffman-La Roche Limited, Gendx, Hologic, Inc., Illumina, Inc., Immucor, Inc., Luminex Corporation, Merck KGaA, Omixon, Qiagen Nv, and Thermo Fisher Scientific are the key players in transplant diagnostics market.

    The Transplant Diagnostics Market is expected to reach US$ 6.54 billion by 2028.

    North America is expected to be the largest transplant diagnostics market during the forecast period.

    The hospital & transplant centers segment is expected to lead the transplant diagnostics market in the coming five years.

    The molecular assay technology segment is expected to remain dominant in the transplant diagnostics market during the forecast period.

    The diagnostic applications segment accounted for the larger share of the transplant diagnostics market.